Atom | Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Due Dates: July 11, 2025 | October 15, 2025 | February 13, 2026 | July 10, 2026 | October 14, 2026

Funding Amounts: Up to $150,000 in direct costs per year; max project period 3 years; cannot exceed parent R01 end date.

Summary: Supports revision applications to clinically validate NCI-supported biomarker assays for cancer detection, prognosis, and treatment response.

Key Information: Only for active NCI R01 projects with ≥2 years remaining; no clinical trials or early-stage technology development.

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing